Readystate Asset Management LP Keros Therapeutics, Inc. Transaction History
Readystate Asset Management LP
- $3.08 Trillion
- Q2 2024
A detailed history of Readystate Asset Management LP transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Readystate Asset Management LP holds 113,823 shares of KROS stock, worth $6.61 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
113,823
Previous 94,373
20.61%
Holding current value
$6.61 Million
Previous $6.25 Billion
16.74%
% of portfolio
0.17%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding KROS
# of Institutions
156Shares Held
27.5MCall Options Held
28.7KPut Options Held
1.8K-
Black Rock Inc. New York, NY2.51MShares$146 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.76MShares$102 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY1.6MShares$92.8 Million0.12% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y91.53MShares$88.6 Million8.43% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.27MShares$73.6 Million1.4% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $1.49B
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...